LBF16306HO01: Difference between revisions
No edit summary |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 6: | Line 6: | ||
|LipidBank=DFA8137 | |LipidBank=DFA8137 | ||
|LipidMaps=LMFA01050143 | |LipidMaps=LMFA01050143 | ||
|SysName=8R-Hydroxy- (4-cis | |SysName=8R-Hydroxy- (cis-4,trans-6,cis-10) -hexadecatrienoic acid | ||
|Common Name=&&8-(R)-Hydroxy- (4Z,6E,10Z) -hexadecatrienoic acid&&8R-Hydroxy- (4Z,6E,10Z) -hexadecatrienoic acid&& | |Common Name=&&8-(R)-Hydroxy- (4Z,6E,10Z) -hexadecatrienoic acid&&8R-Hydroxy- (4Z,6E,10Z) -hexadecatrienoic acid&& | ||
|UV Spectra= lambda max: 234nm epsilon : 23,000 | |UV Spectra= lambda max: 234nm epsilon : 23,000 | ||
Latest revision as of 15:23, 21 October 2010
| LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
| IDs and Links | |
|---|---|
| LipidBank | DFA8137 |
| LipidMaps | LMFA01050143 |
| CAS | |
| KEGG | {{{KEGG}}} |
| KNApSAcK | {{{KNApSAcK}}} |
| mol | LBF16306HO01 |
| 8-(R)-Hydroxy- (4Z,6E,10Z) -hexadecatrienoic acid | |
|---|---|
| |
| Structural Information | |
| 8R-Hydroxy- (cis-4,trans-6,cis-10) -hexadecatrienoic acid | |
| |
| 8(R)-HHxTrE/2,3,4,5-tetranor 12(R)-HETE | |
| Formula | C16H26O3 |
| Exact Mass | 266.18819469799996 |
| Average Mass | 266.37584 |
| SMILES | CCCCCC=CCC(O)C=CC=CCCC(O)=O |
| Physicochemical Information | |
| Metabolism of 12(R)-HETE in corneal tissue produces predominantly the compound resulting from the loss of four carbon atoms through beta -oxidation from C-1 Nishimura_M et al.. This metabolite is 8(R)-hydroxy hexadecatrienoic acid (8(R)-HHxTrE) or 2,3,4,5-tetranor 12(R)-HETE. | |
| Spectral Information | |
| Mass Spectra | |
| UV Spectra | λ max: 234nm ε : 23,000 |
| IR Spectra | |
| NMR Spectra | |
| Other Spectra | |
| Chromatograms | |
| Reported Metabolites, References | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
